| Simeone, Diane M |
University Of California, San Diego
United States |
Biomarker Validation in Pancreatic Cystic Neoplasms |
5U01CA282272-03 |
PAR-21-334 (U01 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Siminski, Suzanne M. |
Frontier Sci & Technology Rsch Fdn, Inc
United States |
CASCADE Coordinating Center |
5U24CA275417-04 |
|
Maria Silvina Frech, Ph.D., M.S. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Clinical Validation Center for Hepatocellular Carcinoma |
5U01CA271887-04 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules |
4U01CA283935-03 |
|
Sidney Fu, M.D. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis |
5R01CA222900-06 |
|
|
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States |
5U01CA230694-05 |
|
|
| Siskind, Leah J |
University Of Louisville
United States |
Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease |
1R01CA305985-01 |
|
Marjorie Perloff, M.D. |
| Skates, Steven J |
Massachusetts General Hospital
United States |
Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer |
5U2CCA271871-03 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Skates, Steven J |
Massachusetts General Hospital
United States |
Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls |
5U01CA260758-05 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |
| Skubitz, Amy Patrice |
University Of Minnesota
United States |
A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection |
5R01CA262153-05 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Christos Patriotis, Ph.D., M.Sc. |
